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Abstract
This special issue covers selected papers from the 18th Bio-Ontologies Special Interest Group meeting and Phenotype
Day, which took place at the Intelligent Systems for Molecular Biology (ISMB) conference in Dublin in 2015. The papers
presented in this collection range from descriptions of software tools supporting ontology development and
annotation of objects with ontology terms, to applications of text mining for structured relation extraction involving
diseases and phenotypes, to detailed proposals for new ontologies and mapping of existing ontologies. Together, the
papers consider a range of representational issues in bio-ontology development, and demonstrate the applicability of
bio-ontologies to support biological and clinical knowledge-based decision making and analysis.
The full set of papers in the Thematic Issue is available at http://www.biomedcentral.com/collections/sig.
Introduction
This special issue originates from the papers presented
in a 2-day meeting, combining the Bio-Ontologies SIG
(Special Interest Group) meeting with a phenotype-
focused Phenotype Day, held at the Intelligent Systems
for Molecular Biology (ISMB) conference in Dublin,
Ireland in 2015. This was the second combined event,
following on from a successful event in 2014 [1]. The
papers that feature in this special issue are a selection of
submissions to the meeting that were extended and sub-
mitted for consideration by the journal. All papers were
substantially revised from the original SIG meeting pa-
pers, and underwent the standard journal peer review
process.
The Bio-Ontologies meeting, as in years past, invited
presentation and discussion of research across a broad
scope, encompassing the organization and dissemination
of knowledge in biomedicine and any aspect of applica-
tion of ontologies in life sciences research. There were
14 submissions to the Bio-Ontologies SIG meeting, and
12 were accepted to the workshop, including six short
papers and six flash updates. Of these, four were
extended for this special issue.
Phenotype Day brought together researchers from a large
number of different domains to discuss aspects of represen-
tation, integration and dissemination of phenotype data
across domains and disciplines. There were 15 submissions
in total to Phenotype Day, with 11 accepted to the workshop
(one full paper, six short papers, one position paper, three
posters). Of these, five appear in this special issue.
Summary of selected papers
In correspondence with the broad selection of topics rep-
resented at the Bio-Ontologies Special Interest Group
meeting, the papers selected for this special issue also
cover this range of topics. The areas of interest included
not only the creation, further development and integration
of existing ontologies, but also their application in phe-
nomics research. Application areas include the representa-
tion and integration of model organism databases as well
as text mining of the scientific literature or clinically
relevant documents, such as electronic health records.
Summary of papers from bio-ontologies
Two papers in this special issue address issues core to the
construction of ontologies for management of biological
information. Vita et al. [2] directly propose an extension
to a previously-proposed Major Histocompatibility Com-
plex (MHC) Restriction ontology called MaHCO [3], con-
structed with the assistance of ontology design patterns,
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while Jupp et al. [4] introduce a web-based tool to ease
authoring of ontologies with built-in support for enforcing
precisely such design patterns.
Specifically, the ontology proposed by Vita et al. [2]
aims to enable representation of MHC molecules in the
Immune Epitope DataBase (IEDB), in terms of their rela-
tion to immunological experiments. These molecules
play an important role in the adaptive immune system,
and because of their wide variation and broad relevance,
pose a challenge to knowledge representation. The
enriched MHC ontology enables logical querying of
MHC molecules, in terms of a protein complex of two
chains, and includes the details of their locus, haplotype
and/or serotype, as well as the haplotype of the host spe-
cies. Finally, the experimental evidence for the MHC re-
striction is also modelled. The authors have provided
users of the IEDB the capability to search complex rela-
tionships among MHC genes and MHC restrictions, in
terms of standard ontology identifiers wherever possible.
In their software article, Jupp et al. [4] introduce the
Webulous application suite, including an add-on appli-
cation for Google Sheets that allows population of ontol-
ogy design templates with content, and demonstrate it
with a case study using the Experimental Factor Ontol-
ogy (EFO). This software allows addition of ontology
content in bulk, while ensuring consistency of that con-
tent. It includes access to BioPortal services [5] that
allow users to search for existing ontology terms to fa-
cilitate ontology integration and reuse. The templates
themselves allow automatic creation of relations or as-
sertions from data entered into a spreadsheet, using con-
sistent transformation of the data to OWL axioms. In
short, it supports large-scale ontology development with
the assistance of domain experts who may not them-
selves be ontology experts.
Webulous is used to create terms in EFO for the work
described by Sarntivijai et al. [6]. In the context of the
Centre for Therapeutic Target Validation (CTTV), they
aim to represent disease-phenotype associations, with
the objective of linking rare and common diseases to en-
able identification of potential therapeutic (drug) targets.
A particular representational challenge tackled in this re-
search is to capture phenotypes that are only sometimes
associated to a disease, to reflect that not all relevant
phenotypes will be present in every presentation. This is
done through the use of a generic association model
OBAN (Open Biomedical AssociatioN) which allows
qualification of association with evidence and, eventu-
ally, frequency. The authors describe the use of text
mining of the literature to identify candidate disease-
phenotype associations that are curated and transformed
into the OBAN model using EFO.
Leung and Dumontier [7] similarly apply text mining
in the context of disease associations, in their case
considering drug-disease associations as extracted from
drug structured product labels. The identified associa-
tions are compared to the clinical practice guidelines,
with the finding that there is not a large overlap between
the disease indications for drugs in their structured la-
bels, and the indications for those same drugs in clinical
practice guidelines. The authors did find that using taxo-
nomic relationships among drugs did improve the over-
lap, but a substantial gap remained. The study raises
concerns about the inconsistent evidence between these
drug-related information sources and has implications
for clinical decision making in evidence-based practice.
Summary of papers from Phenotype Day
Bello and colleagues report in “Inferring Gene-to-
Phenotype and Gene-to-Disease Relationships at Mouse
Genome Informatics: Challenges and Solutions” [8] on an
algorithm for the assignment of gene-phenotype and
gene-disease association from the existing genotype-
phenotype links contained in the Mouse Genome Inform-
atics (MGI) database. The algorithm has been applied to
the existing wealth of data in this database to the effect
that 2100 mouse markers could be linked to human dis-
ease and 16,000 mouse markers could be linked to pheno-
types. The resulting gene-phenotype and gene-disease
associations are provided as part of the database’s web
pages and can be downloaded by interested parties.
In “Interoperability between phenotypes in research
and healthcare terminologies - Investigating partial map-
pings between HPO and SNOMED CT” [9], Dhombres
and colleagues report about their investigations to deter-
mine partial alignments between both the Human
Phenotype Ontology (HPO) and SNOMED CT using
modifier terms and HPO’s subsumption relations. Using
the suggested approach, the authors identified partial
mappings for 92% of the investigated HPO terms. 30%
out of these 92% partial mappings correspond to equiva-
lence statements, while the remaining 60% follow a
next-best approach to allow for traversing between both
ontologies.
Mowery et al. in “Extracting a Stroke Phenotype Risk
Factor from Veteran Health Administration Clinical Re-
ports: An Information Content Analysis” conducted ex-
periments to investigate the report of a stenosis
phenotype in relation to stroke in radiology and text in-
tegration utility notes [10]. These notes were gathered
from the Veteran Health Administration electronic
health records. The authors analyse sections and pure
textual representations in both types of records using
pyConText. The results show that there are differences
in the performance of stenosis identification and the
location of reporting for both types of note. Yet the
authors conclude that pyConText can still be used to fil-
ter chart reports into significant and no/insignificant
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stenosis findings for the data from the Veteran Health
Administration, facilitating further studies on effective-
ness of stroke prevention.
Tudose et al. present in “PhenoImageShare: An image
annotation and query infrastructure” [11] a phenotype
annotation infrastructure for image data. Images are
imported from four different resources, leveraging ontol-
ogy annotations from the original repository. Further-
more, images can be manually annotated using a variety
of ontologies, such as UBERON or the Mammalian
Phenotype Ontology (MP). The annotation service is in-
dependent from species and image data. PhenoImage-
Share holds to date ~118 k images (retrieved from
mouse and fly databases) associated to anatomical or
phenotype concepts (so called regions of interest). The
phenotype image data can be accessed either via a web
interface or an API.
The manuscript “Reporting phenotypes in mouse
models when considering body size as a potential con-
founder” by Oellrich and colleagues [12] investigates the
challenges surrounding confounding variables in experi-
mental studies associating genotypes and phenotypes.
The authors provide a case study based on the experi-
mental results released by the International Mouse Phe-
notyping Consortium (IMPC) and further discuss the
limitations of current ontological representation to re-
port on confounding effects. The authors conclude that
further discussion is needed within the community to
derive a community-approved representation and dis-
semination of confounders in genotype-phenotype asso-
ciation studies.
Conclusions
The storage, retrieval, and analysis of ever-growing bio-
logical information is complicated by the complexity and
diversity of that information. To the extent that
consistency in representation of this information can be
achieved through the use of a common terminology and
validated relationships, and that strategies for modeling
rare, confounded, or highly contextual relationships can
be developed, it is possible to make progress on making
that information findable and available for further inves-
tigation. The papers in this thematic issue contribute to
those goals, both by addressing the foundational issues
of representational expressivity as well as consistency of
use of bio-ontologies, and by demonstrating the applica-
tion of such structured representations to support infer-
ence from biological or biomedical data, on tasks
ranging from determination of stroke risk factors and
predictions of novel gene-disease associations. The pa-
pers raise some important challenges yet add to the body
of research that establishes the promise of improved bio-
medical information access and analysis.
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